HealthBanks Biotech Competitors and Similar CompaniesClear all

HealthBanks Biotech's competitors and similar companies include VLVbio, TOMA Biosciences and 3D Medicines.
HealthBanks Biotech
HealthBanks Biotech
HealthBanks Biotech is a company that provides cord blood banking solutions.
VLVbio
VLVbio
VLVbio is a company devoted to the invention and development of PEVIVA Keratin 18 biomarkers M30 and M65 for the measurement of epithelial cell death in liver disease and oncology.
TOMA Biosciences
TOMA Biosciences
TOMA Biosciences is a company providing a sequencing solution to identify changes in the DNA of cancer tumors.
3D Medicines
3D Medicines
3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs.
Founding Date
Founding Date
2001
Founding Date
2013
Founding Date
2011
Founding Date
2010
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Irvine, US HQ
Locations
HQ
Locations
Holland, US HQ
Locations
Shanghai, CN HQ
Singapore, SG
Dubai, AE
Fremont, US
Employees
Employees
14
Employees
9
Employees
9
Employees
70030% decrease

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 7.8k (over 7 years ago)
Latest funding round
$ 140m (over 5 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 12.3m
Total funding raised
$ 281m
For sources of this data, please see the company profile

View Company Profiles

VLVbio
HQ
Employees
9

VLVbio is a company devoted to the invention and development of PEVIVA Keratin 18 biomarkers M30 and M65 for the measurement of epithelial cell death in liver disease and oncology.

View company
TOMA Biosciences
HQ
Holland, US
Employees
9

TOMA Biosciences is a company providing a sequencing solution to identify changes in the DNA of cancer tumors.

View company
3D Medicines
HQ
Shanghai, CN
Employees
700↓ 30% decrease

3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs.

View company